Literature DB >> 8158191

Single fibre EMG studies in chronic fatigue syndrome: a reappraisal.

L Roberts1, E Byrne.   

Abstract

Single fibre EMG studies were carried out on the right extensor digitorum communis muscle in 30 subjects with chronic fatigue syndrome and in 30 age and sex matched controls. Abnormal jitter was seen in five patients with chronic fatigue syndrome. Slight but significant differences between the mean consecutive differences in the remainder of the chronic fatigue subjects and the control subjects were recorded. Overall the differences were so minor that it seems unlikely that a disturbance of neuromuscular function as reflected by jitter measurement has a pathogenetic role. It is suggested that the increased jitter seen may be explained by the effects of the variability of motor unit firing rates on the myogenic component of the jitter.

Entities:  

Mesh:

Year:  1994        PMID: 8158191      PMCID: PMC1072834          DOI: 10.1136/jnnp.57.3.375

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  Chronic fatigue syndrome: a working case definition.

Authors:  G P Holmes; J E Kaplan; N M Gantz; A L Komaroff; L B Schonberger; S E Straus; J F Jones; R E Dubois; C Cunningham-Rundles; S Pahwa
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

2.  Electrophysiological studies in the post-viral fatigue syndrome.

Authors:  G A Jamal; S Hansen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-07       Impact factor: 10.154

3.  Immunological abnormalities in the chronic fatigue syndrome.

Authors:  A R Lloyd; D Wakefield; C R Boughton; J M Dwyer
Journal:  Med J Aust       Date:  1989-08-07       Impact factor: 7.738

4.  Chronic fatigue and myalgia syndrome: mitochondrial and glycolytic studies in skeletal muscle.

Authors:  E Byrne; I Trounce
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

5.  Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection.

Authors:  M Tobi; A Morag; Z Ravid; I Chowers; V Feldman-Weiss; Y Michaeli; E Ben-Chetrit; M Shalit; H Knobler
Journal:  Lancet       Date:  1982-01-09       Impact factor: 79.321

6.  Excessive intracellular acidosis of skeletal muscle on exercise in a patient with a post-viral exhaustion/fatigue syndrome. A 31P nuclear magnetic resonance study.

Authors:  D L Arnold; P J Bore; G K Radda; P Styles; D J Taylor
Journal:  Lancet       Date:  1984-06-23       Impact factor: 79.321

7.  The mental health of patients with a chief complaint of chronic fatigue. A prospective evaluation and follow-up.

Authors:  P Manu; D A Matthews; T J Lane
Journal:  Arch Intern Med       Date:  1988-10

8.  Normal muscle strength and fatigability in patients with effort syndromes.

Authors:  M J Stokes; R G Cooper; R H Edwards
Journal:  BMJ       Date:  1988-10-22

9.  Muscle strength, endurance and recovery in the post-infection fatigue syndrome.

Authors:  A R Lloyd; J P Hales; S C Gandevia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-10       Impact factor: 10.154

10.  Muscle performance, voluntary activation, twitch properties and perceived effort in normal subjects and patients with the chronic fatigue syndrome.

Authors:  A R Lloyd; S C Gandevia; J P Hales
Journal:  Brain       Date:  1991-02       Impact factor: 13.501

View more
  3 in total

1.  Single fibre EMG studies in chronic fatigue syndrome: a reappraisal.

Authors:  S Connolly; C J Fowler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

2.  Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome.

Authors:  R J Lane; M C Barrett; D Woodrow; J Moss; R Fletcher; L C Archard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154

3.  In the spiral of history: SARS-Cov-2 infection.

Authors:  Mamede de Carvalho
Journal:  Clin Neurophysiol       Date:  2021-05-26       Impact factor: 3.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.